BreachRx
PrivateLast Round
Series A
May 19, 2025
Total Funding Raised
$21.5M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
BreachRx operates in Cybersecurity and is based in San Francisco, California. Its latest recorded funding round was a Series A round in May 2025.
BreachRx is a cybersecurity company that provides an intelligent incident response management platform designed to automate and coordinate enterprise-wide response to security incidents.
Sector
Cybersecurity
Verticals
Incident Response, Compliance & Risk, InsurTech
Business Model
B2B
Customer Profile
Subscription SaaS
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
BreachRx Comparables
Compare BreachRx with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| CYGNVS | 87% | |
| Cytactic | 83% | |
| IR-OS | 79% |
For institutional investors. Book with your work email.
BreachRx Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | May 19, 2025 | ||||
| Seed | Apr 16, 2024 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
BreachRx Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Overline | Seed, Series A |
| SYN Ventures | Series A, Seed |
| Silver Buckshot | Series A |
| Ballistic Ventures | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 24, 2026
Monthly visitors increased 77% MoM, reaching 4K.
- May 19, 2026
Grew 18% QoQ, from 34 to 40 employees.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- launchesOct 1, 2026
BreachRx launches Out-of-Band Comms, a Rex Platform expansion that provides secure communications and collaboration—including email, chat, meetings, workspaces, and mobile executive visibility—for managing cyber incidents when corporate systems cannot be trusted, in California on Oct 1st '26.
- launchesSep 24, 2026
BreachRx launches AI Tabletops on Demand powered by Rex AI in California on Sep 24th '26, enabling organizations to create and run realistic response exercises in minutes for continuous readiness practice.
- launchesSep 24, 2026
BreachRx launches AI Tabletops on Demand, an agentic AI solution that creates and runs realistic enterprise-wide tabletop simulations, in California on Sep 24th '26.
For institutional investors. Book with your work email.
BreachRx Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about BreachRx's valuation, stock price, and market status.
Is BreachRx a public or private company?
BreachRx is a private company.
What is the current stock price of BreachRx?
BreachRx is a private company, so its shares have no public market price. Caplight tracks BreachRx's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is BreachRx worth (valuation)?
Valuation information for BreachRx is not publicly available.
Can I buy BreachRx stock?
BreachRx shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was BreachRx's last funding round?
BreachRx's most recent funding round was Series A on May 19, 2025.
Who are the main investors in BreachRx?
Key investors in BreachRx include SYN Ventures, Ballistic Ventures.
Will BreachRx IPO soon?
No public IPO plans have been announced for BreachRx.
How can I track BreachRx secondary market activity?
Caplight tracks bids, offers, and trades in BreachRx's shares on secondary markets.